Found: 27
Select item for more details and to access through your institution.
UGT1A1 polymorphism and hyperbilirubinemia in a patient who received sorafenib.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 65, n. 1, p. 1, doi. 10.1007/s00280-009-1096-4
- By:
- Publication type:
- Article
Combination analyses of anti-cancer drugs on human neuroendocrine tumor cell lines.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 65, n. 1, p. 5, doi. 10.1007/s00280-009-0997-6
- By:
- Publication type:
- Article
PNAS-4, a novel pro-apoptotic gene, can potentiate antineoplastic effects of cisplatin.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 65, n. 1, p. 13, doi. 10.1007/s00280-009-0998-5
- By:
- Publication type:
- Article
Weekly docetaxel in patients with platinum-refractory metastatic or recurrent squamous cell carcinoma of the head and neck.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 65, n. 1, p. 27, doi. 10.1007/s00280-009-0999-4
- By:
- Publication type:
- Article
A phase I and pharmacokinetics study of intravenous calcitriol in combination with oral dexamethasone and gefitinib in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 65, n. 1, p. 33, doi. 10.1007/s00280-009-1000-2
- By:
- Publication type:
- Article
ABT-737, a BH3 mimetic, induces glutathione depletion and oxidative stress.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 65, n. 1, p. 41, doi. 10.1007/s00280-009-1001-1
- By:
- Publication type:
- Article
Preclinical pharmacokinetics and in vitro metabolism of brivanib (BMS-540215), a potent VEGFR2 inhibitor and its alanine ester prodrug brivanib alaninate.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 65, n. 1, p. 55, doi. 10.1007/s00280-009-1002-0
- By:
- Publication type:
- Article
Safety and pharmacokinetic trial of docetaxel plus an Astragalus-based herbal formula for non-small cell lung cancer patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 65, n. 1, p. 67, doi. 10.1007/s00280-009-1003-z
- By:
- Publication type:
- Article
Phase II and pharmacokinetic trial of rebeccamycin analog in advanced biliary cancers.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 65, n. 1, p. 73, doi. 10.1007/s00280-009-1005-x
- By:
- Publication type:
- Article
A dose-finding and pharmacokinetic study of nedaplatin in elderly patients with advanced non-small cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 65, n. 1, p. 79, doi. 10.1007/s00280-009-1006-9
- By:
- Publication type:
- Article
Biological reactive intermediates that mediate dacarbazine cytotoxicity.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 65, n. 1, p. 89, doi. 10.1007/s00280-009-1007-8
- By:
- Publication type:
- Article
Pharmacokinetic analysis of irinotecan plus bevacizumab in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 65, n. 1, p. 97, doi. 10.1007/s00280-009-1008-7
- By:
- Publication type:
- Article
Successful desensitization with cetuximab after an infusion reaction to panitumumab in patients with metastatic colorectal cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 65, n. 1, p. 107, doi. 10.1007/s00280-009-1009-6
- By:
- Publication type:
- Article
A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 65, n. 1, p. 113, doi. 10.1007/s00280-009-1011-z
- By:
- Publication type:
- Article
A dose escalation and pharmacokinetic study of the biweekly administration of paclitaxel, gemcitabine and oxaliplatin in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 65, n. 1, p. 121, doi. 10.1007/s00280-009-1013-x
- By:
- Publication type:
- Article
Phase I study of larotaxel administered as a 1-h intravenous infusion every 3 weeks to Japanese patients with advanced solid tumours.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 65, n. 1, p. 129, doi. 10.1007/s00280-009-1014-9
- By:
- Publication type:
- Article
Pharmacokinetics of temozolomide administered in combination with O6-benzylguanine in children and adolescents with refractory solid tumors.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Pharmacokinetics of temozolomide administered in combination with O<sup>6</sup>-benzylguanine in children and adolescents with refractory solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 65, n. 1, p. 137, doi. 10.1007/s00280-009-1015-8
- By:
- Publication type:
- Article
The potential of vitamin K<sub>3</sub> as an anticancer agent against breast cancer that acts via the mitochondria-related apoptotic pathway.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 65, n. 1, p. 143, doi. 10.1007/s00280-009-1016-7
- By:
- Publication type:
- Article
A phase II trial of biweekly oxaliplatin with simplified schedule of 48-h infusion of high-dose 5-fluorouracil and leucorvin for advanced biliary tract carcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 65, n. 1, p. 151, doi. 10.1007/s00280-009-1018-5
- By:
- Publication type:
- Article
Phase II study of S-1 monotherapy in paclitaxel- and cisplatin-refractory gastric cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 65, n. 1, p. 159, doi. 10.1007/s00280-009-1019-4
- By:
- Publication type:
- Article
Phase I and pharmacokinetic study of cisplatin and troxacitabine administered intravenously every 28 days in patients with advanced solid malignancies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 65, n. 1, p. 167, doi. 10.1007/s00280-009-1020-y
- By:
- Publication type:
- Article
Preclinical pharmacokinetics and in vitro activity of ON 01910.Na, a novel anti-cancer agent.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 65, n. 1, p. 177, doi. 10.1007/s00280-009-1022-9
- By:
- Publication type:
- Article
Hepatic portal venous gas in a patient with metastatic non-small cell lung cancer on bevacizumab therapy: a case report and review of the literature.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 65, n. 1, p. 187, doi. 10.1007/s00280-009-1104-8
- By:
- Publication type:
- Article
The polyamine analog PG11047 potentiates the antitumor activity of cisplatin and bevacizumab in preclinical models of lung and prostate cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 65, n. 1, p. 191, doi. 10.1007/s00280-009-1105-7
- By:
- Publication type:
- Article
K-ras status in squamous cell anal carcinoma (SCC): it's time for target-oriented treatment?
- Published in:
- 2009
- By:
- Publication type:
- journal article
K-ras status in squamous cell anal carcinoma (SCC): it’s time for target-oriented treatment?
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 65, n. 1, p. 197, doi. 10.1007/s00280-009-1117-3
- By:
- Publication type:
- Article